Report copyright - Supplementary Materials for · 4 crizotinib-resistant H3122 cells (CR1, CR2, and CR3), and control cell lines expressing wild-type ALK (HCC827, PC9 and A549) were treated with NVP-TAE684
Please pass captcha verification before submit form